Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Concurrent Lepromatous Leprosy and Active Tuberculosis in A Young Male: A Complex Diagnostic and Therapeutic Challenge with Hematologic Manifestations

González JFM, González ALR, Gamiño AED, et al. Everant Journals. International Journal of Medical Science and Clinical Research Studies. 2025; 05 (12) : 2058-2062.
Download PDF
Publication

Assessment of leprosy in post-insurgency Northeastern Nigeria: a retrospective study

Tyndall JA, John S, Abdulkarim S, et al. Lepra. Leprosy Review. 2026; 97 (1) : 1-15.
Download PDF
Publication

Impact of Dapsone (MDT/WHO) on hematological tests of leprosy patients: A retrospective cohort study

da Silva CM, Albertino GS, Wiezel JA, et al. openRxiv. 2025;
Download PDF
Publication

Advancing leprosy risk prediction through identification of a whole blood host transcriptomic biomarker signature including non-coding genes.

Almeida M, Gherardi E, van Veen S, et al. Scientific reports. 2025;
Download PDF
Publication

Effectiveness of Slit Skin Smear Versus Fite-Faraco Staining on Histopathology as a Method of Diagnosis in Leprosy - a Retrospective Hospital-Based Study.

Anandani G, Bhise M, Goswami P, et al. Maedica. 2025; 20 (4) : 787-794.
Download PDF
Publication

A Case Report:Cutaneous Leishmaniasis Mimicking Leprosy in an Immunocompetent Young Adult: A Diagnostic and Therapeutic Challenge in the old world

Albajori R, AlHader H, ALshawa K. Elsevier BV. JAAD Case Reports. 2025;
Download PDF
Publication

Molecular Viability Assay: Improving Leprosy Diagnosis beyond Current Gold Standard

Clara Imaniar , Ibnu Agus Ariyanto , Yeva Rosana . Eksakta: Berkala Ilmiah Bidang MIPA. 2025; 26 (4) : 456-467.
Download PDF
Publication

Rare multisystemic complications with delayed diagnosis in two cases of leprosy

Khallouki M, Bendaoud L, Serghini S, et al. Our Dermatology Online. Our Dermatology Online. 2025;
Publication

Transepidermal Elimination of Mycobacterium Leprae: An Overlooked Phenomenon

Shastry V, Shastry R. Ovid Technologies (Wolters Kluwer Health). Indian Dermatology Online Journal. 2025;
Download PDF
Publication

Molecular detection of mutations in the gyrA gene associated with fluoroquinolone resistance in Mycobacterium leprae strains from leprosy patients in Adzopé, Côte d’Ivoire

Roger DB, Christiane AA, Jean-Luc TG, et al. Lepra. Leprosy Review. 2025; 96 (4) : 1-8.
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Diagnostic tests

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD